Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial. (2014)

First Author: Sestak I
Attributed to:  CIMA: The Centre for Integrated Research into Musculoskeletal Ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(14)71035-6

PubMed Identifier: 25456365

Publication URI: http://europepmc.org/abstract/MED/25456365

Type: Journal Article/Review

Volume: 15

Parent Publication: The Lancet. Oncology

Issue: 13

ISSN: 1470-2045